Syneos Health Expands Catalyst Site Program to Thailand

MORRISVILLE, N.C. – septembre 28, 2023 – Syneos Health^®, a leading fully integrated biopharmaceutical solutions organization, today announced that it has signed an agreement with Maha Chakri Sirindhorn Clinical Research Center Under the Royal Patronage, Faculty of Medicine, Chulalongkorn University (ChulaCRC.) This agreement expands the Company’s clinical trial capabilities across a broader range of therapeutic areas in Thailand.

The agreement signifies the first Catalyst Site in Thailand, extending the Program’s solutions to local customers in the country. Introduced in 2016 to strengthen collaborations with clinical research sites worldwide, the Program harnesses insights from sites across the globe with the goals of driving continuous improvement and developing best practices in clinical research delivery.

“Syneos Health is committed to building longstanding, productive site relationships that aim to deliver consistent quality, predictable results and streamlined processes for clinical trials,” said Serena Chan, Head of Asia Pacific, Clinical Operations and General Manager of Southeast Asia, Clinical Development, Syneos Health. “We look forward to working closely with the ChulaCRC to address customers’ unique and complex needs.”

“We’re proud to be selected as the first Catalyst Site in Thailand and look forward to collaborating with Syneos Health to streamline the clinical trial process and provide high-quality clinical trial services,” said Prof. Thanyawee Puthanakit, Director, ChulaCRC.

About Syneos Health

Syneos Health^® is a leading fully integrated  biopharmaceutical solutions organization built to accelerate customer success.  We translate unique clinical, medical affairs and commercial insights into  outcomes to address modern market realities. 

We bring together a talented team of  professionals, who work across more than 110 countries, with a deep  understanding of patient and physician behaviors and market dynamics.

Together we share insights, use the latest technologies and apply advanced  business practices to speed our customers’ delivery of important therapies to  patients.

Syneos Health supports a diverse,  equitable and inclusive culture that cares for colleagues, customers, patients,  communities and the environment. 

To learn more about how we are Shortening the distance from lab to life^®, visit syneoshealth.com.

Investor Relations Contact:  Ronnie Speight Senior Vice President, Investor Relations +1 919 745 2745 [email protected]

Press/Media Contact: Gary Gatyas Executive Director, External Communications +1 908 763 3428  [email protected]